How Much Weight Can You Lose from Mounjaro?

Last reviewed: July 15, 2026

Last updated: July 15, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide is a dual glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that helps control appetite and blood sugar. In landmark clinical trials, tirzepatide users lost between 16% and 22% of their starting body weight within 52 weeks—substantially more than older GLP-1 agents alone. Your individual results will differ based on your genetic makeup, adherence, diet, and exercise habits.

What Does Clinical Trial Data Show About Tirzepatide Weight Loss?

The SURMOUNT trials, the largest studies of tirzepatide for weight management, enrolled over 2,500 adults with obesity or overweight and at least one weight-related health condition. Participants receiving the highest tirzepatide dose lost an average of 22.5% of their starting body weight, compared to 2.4% in the placebo group. Lower doses produced meaningful but smaller losses: the mid-range dose achieved approximately 20% weight reduction. These results represent a roughly threefold improvement over earlier GLP-1 monotherapy agents.

Weight loss typically accelerates during months 2 through 6, then plateaus somewhat, though continued gradual losses are common through month 12 and beyond. Most participants reached their maximum weight loss between 6 and 9 months of treatment. Importantly, when tirzepatide was discontinued, weight regain occurred in many patients, highlighting that ongoing therapy maintains results. Individual variation is substantial: some patients lose 30% or more of body weight, while others achieve 10–15%, depending on genetics, compliance, and lifestyle factors.

How Your Genetics Influence Tirzepatide Weight Loss Response

Your response to tirzepatide is shaped by genetic variations in appetite-control pathways. The GLP1R gene (rs6923761 variant) affects how efficiently your body's GLP-1 receptor signals fullness; a variant copy may require slightly longer response times. The GIPR gene (rs1800437) directly influences how well you respond to GIP signaling—tirzepatide's dual action. The FTO gene (rs9939609) is strongly linked to genetic predisposition for higher body weight and appetite drive. MC4R variations affect melanocortin signaling, a central hunger regulator in the brain.

The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Factors That Affect How Much Weight You'll Lose

Starting body weight is one of the strongest predictors of absolute pounds lost: a 250-pound person losing 20% drops 50 pounds, while a 180-pound person loses 36 pounds at the same percentage. However, percentage weight loss (which matters more medically) is often similar across starting weights. Age, sex, baseline insulin resistance, and existing metabolic health also influence results. Patients with type 2 diabetes often lose slightly less weight than those without diabetes, though their metabolic improvements are equally important.

Your behavior during treatment matters enormously. Patients who reduce calorie intake, increase physical activity, and maintain consistent tirzepatide dosing see substantially better results than those who rely on medication alone. Sleep quality, stress levels, and medication adherence directly impact weight loss velocity. Dose consistency—taking your injection or oral dose on schedule—ensures stable appetite suppression and steady progress toward your goals.

PlexusDx Tirzepatide Injection: Accessible, Personalized Dosing

PlexusDx offers compounded tirzepatide injection from licensed 503A compounding pharmacies at a flat monthly rate of $289, with no flat per-compound pricing increases. Your dose may need to go up as you progress through titration, but your price remains stable—a transparent model that removes cost surprises. All 50 states are served with no insurance requirement, no membership fees, and HSA/FSA eligibility, making precision weight loss accessible to more patients.

The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes GLP1R, GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How much weight can I realistically expect to lose with tirzepatide?

Clinical trials show average weight loss of 16–22% of starting body weight over 12 months, with the highest doses producing the largest losses. Your individual result depends on genetics, starting weight, dose tolerance, lifestyle changes, and treatment adherence. Many PlexusDx patients report meaningful progress by month 3, with plateau around month 6–9.

Is tirzepatide more effective for weight loss than semaglutide?

Yes. Tirzepatide's dual GIP/GLP-1 mechanism produces approximately 4–6 percentage points more weight loss than semaglutide monotherapy in head-to-head trials. Tirzepatide's broader action on two appetite pathways makes it particularly effective for patients with severe genetic predispositions to weight gain or appetite dysregulation.

How much does tirzepatide cost at PlexusDx?

PlexusDx's compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan) with no flat per-compound pricing increases. The service is available in all 50 states, requires no insurance, and qualifies for HSA/FSA accounts. Many patients add the Precision Peptide Genetic Test ($99 one-time) to personalize their dosing strategy.

What side effects should I expect, and do they affect weight loss?

Common side effects include nausea, vomiting, constipation, and fatigue, especially during the first 1–2 weeks and when increasing doses. Most side effects diminish within days to weeks as your body adapts. Severe nausea may reduce food intake further, but mild nausea is preferable; if it's intolerable, your provider can slow titration or adjust your dose.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

PlexusDx's Precision Peptide Genetic Test analyzes 14 metabolic pathways and 150+ insights, including GLP1R, GIPR, FTO, and MC4R variants that directly influence tirzepatide response and appetite regulation. Patients with certain genetic profiles may expect faster response or benefit from higher doses, while others may achieve better results with slower titration—enabling truly personalized treatment from day one.

Related Reading

• Can My Dna Tell Me How Do You Lose Weight
• Can A Dna Test Tell Me How Do You Lose Weight
• Can You Get A Dna Test To See How Do You Lose Weight
• Mounjaro For Losing Weight

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.